InfectoGnostics – Research campus for the diagnosis of infectious diseases and infection research
The InfectoGnostics research campus is a public-private partnership developing new methods in infection diagnostics. In a triad of technology, application and production, more than 30 partners from science, medicine and industry are developing marketable solutions for rapid and cost-effective on-site analysis (point-of-care testing) of infections – such as pneumonia (e.g. caused by antibiotic-resistant pathogens) and tuberculosis in human medicine, animal diseases, and pathogen detection in food. Within the joint project "Pneumonia in Immunosuppression" seven public and private partners aim at developing a reliable, rapid and non-invasive diagnostic tool for pneumonia pathogens and their resistance. (Project video below only available in German).
Public-private Partnership for Innovation
The InfectoGnostics research campus is one of nine winners of the funding initiative "Research campus - Public-private Partnership for Innovation" of the Federal Ministry of Education and Research (BMBF). This initiative is a new tool in the Federal Government’s "Hightech Strategy". After a positive evaluation by the jury, InfectoGnostics has entered the first five-year main phase in February 2015.
With the help of this public-private partnership, a European centre for infection diagnostics will be established that will be characterised by excellent research and training and the interaction of basic research, application and technology transfer.